Jade Biosciences Inc share price logo

Jade Biosciences Inc Share Price

NASDAQ: JBIO

Small Cap

$14.12

+0.07

(+0.50%)

Live

as on

Jade Biosciences Inc Stock Performance

as on March 10, 2026 at 4:09 am IST

  • Day's Low

    Day's High

    $14.04
    $14.62
    downward going graph

    0.57%

    Downside

    3.54%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $6.57
    $17.71
    downward going graph

    53.51%

    Downside

    25.42%

    Upside

    downward going graph

Jade Biosciences Inc share price movements today

Previous Close
$14.05
Open
$14.47
Volume
417.4K
Day's Low - High
$14.04 - $14.62
52 Week Low - High
$6.57 - $17.71

Jade Biosciences Inc Historical Returns

1 Month Return
-2.9 %
3 Month Return
+ 4.07 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Jade Biosciences Inc Stock Fundamentals & Key Indicators

Check Jade Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$684.5M

EPS (TTM)

-2.9543

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

0.00%

Jade Biosciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Jade Biosciences Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Jade Biosciences Inc image
Jade Biosciences Inc
NA$684.5MNANA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$42.5B132.9%137.038.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$116.0B113.37%29.8532.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$33.3BNA590.435.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$80.3B61.46%18.3131.41%

Jade Biosciences Inc Stock’s Investor Sentiment and Interest

Search interest for Jade Biosciences Inc Stock has increased by 117% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:117% versus previous 30 day period

Jade Biosciences Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2024
Jun 2025
Sep 2025
Total Revenue
-
-
-
Gross Profit
0
0
0
Operating Income
-14
-27
-27
EBITDA
-16
-32
-25
Interest Expense
-
-
-
Depreciation
-
-
0
Income Before Tax
-16
-32
-25
Income Tax Expense
-
-
-
Net Income
-16
-32
-25
Net Profit Margin
0.00%
0.00%
0.00%

Jade Biosciences Inc Annual Profit & Loss

All numbers in Millions USD

Total Revenue
Gross Profit
Operating Income
EBITDA
Interest Expense
Depreciation
Income Before Tax
Income Tax Expense
Net Income
Net Profit Margin

Jade Biosciences Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-20
-23
-24
-16
-5
-38
-32
-25
-31
Operating Cash Flow
-14
-23
-20
37
-11
-
-36
-22
-33
Investing Cash Flow
5
8
18
-26
13
-
-12
-148
-98
Financing Cash Flow
0
0
24
69
0
-
190
-
170
Change in Cash
-8
-14
21
0
2
-
176
-170
-50

Jade Biosciences Inc Annual Cash Flow

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-22
-51
-75
-69
-127
Operating Cash Flow
-27
-39
-56
-71
-94
Investing Cash Flow
-113
6
11
56
-247
Financing Cash Flow
190
0
45
25
360
Change in Cash
49
-31
1
10
-33

Insights on Jade Biosciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, JBIO stock has moved up by 84.4%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, JBIO has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 72.4% return, outperforming this stock by 109.6%

About Jade Biosciences Inc

Jade Biosciences, Inc. is a biotechnology company, which is focused on developing therapies for autoimmune diseases. The Company’s lead asset, JADE-001, is an investigational anti-A PRoliferation-Inducing Ligand (APRIL) monoclonal antibody for the treatment of Immunoglobulin A (IgA) nephropathy (IgAN), an autoimmune condition in which the kidney is damaged by pathogenic IgA containing immune complexes, leading to proteinuria and kidney function decline, and potentially progressing to end-stage kidney disease requiring dialysis or transplantation. Designed to block the APRIL protein, JADE-001 targets an underlying cause of IgAN, offering the potential to reduce pathogenic IgA levels, decrease proteinuria, and preserve kidney function over the long term. The Company’s pipeline also includes two undisclosed antibody discovery programs: JADE-002 and JADE-003, which are in preclinical development.
OrganisationJade Biosciences Inc
HeadquartersBuilding 23, Waltham, MA, United States, 02453
CEOMr. Tom Frohlich
E-voting on sharesClick here to vote

Key Management of Jade Biosciences Inc

Name

Title

Ms. Sandy Lewis

Senior Vice President, Biometrics & Clinical Strategy

Mr. Tom Frohlich

CEO & Director

Mr. Bradford D. Dahms Ph.D.

CFO & Treasurer

Ms. Lori Stewart

Senior Vice President of People

Dr. Jason Wright Ph.D.

Senior Vice President of Chemistry, Manufacturing & Controls

Ms. Amy Sullivan

Senior Vice President of Development Operations

Dr. Andrew James King D.V.M., Ph.D.

Chief Scientific Officer & Head of R&D

Ms. Elizabeth Balta J.D.

General Counsel & Corporate Secretary

Mr. Jonathan Quick

Senior Vice President of Finance

Ms. Valerie Fauvelle

Senior Vice President of Regulatory & Quality

FAQs

What is Jade Biosciences Inc share price today?

Jade Biosciences Inc share price today is $14.12 as on . Jade Biosciences Inc share today touched a day high of $14.62 and a low of $14.04.

What is the 52 week high and 52 week low for Jade Biosciences Inc share?

Jade Biosciences Inc share touched a 52 week high of $17.71 on and a 52 week low of $6.57 on . Jade Biosciences Inc stock price today i.e. is trending at $14.12,which is 20.27% down from its 52 week high and 115.08% up from its 52 week low.

What is Jade Biosciences Inc's market capitalisation today?

Jade Biosciences Inc market capitalisation is $0.00T as on .

How to invest in Jade Biosciences Inc Stock (JBIO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Jade Biosciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Jade Biosciences Inc Shares that will get you 0.1062 shares as per Jade Biosciences Inc share price of $14.12 per share as on March 9, 2026 at 10:39 pm IST.

What is the minimum amount required to buy Jade Biosciences Inc Stock (JBIO) from India?

Indian investors can start investing in Jade Biosciences Inc (JBIO) shares with as little as ₹92.306 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹923.06 in Jade Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Jade Biosciences Inc share’s latest price of $14.12 as on March 9, 2026 at 10:39 pm IST, you will get 0.7082 shares of Jade Biosciences Inc. Learn more about fractional shares .